Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Asanga Abeyaratne"'
Autor:
Sandawana William Majoni, Jane Nelson, Jessica Graham, Asanga Abeyaratne, David Kiran Fernandes, Sajiv Cherian, Geetha Rathnayake, Jenna Ashford, Lynn Hocking, Heather Cain, Robert McFarlane, Paul Damian Lawton, Federica Barzi, Sean Taylor, Alan Cass
Publikováno v:
BMC Nephrology, Vol 24, Iss 1, Pp 1-10 (2023)
Abstract Background Ferritin levels are used to make decisions on therapy of iron deficiency in patients with chronic kidney disease (CKD). Hyperferritinaemia, common among patients with CKD from the Northern Territory (NT) of Australia, makes use of
Externí odkaz:
https://doaj.org/article/074dc5383fe04ae189b612f30f1efbb7
Publikováno v:
BMC Nephrology, Vol 23, Iss 1, Pp 1-9 (2022)
Abstract Aim Royal Darwin Hospital (RDH) is the main tertiary hospital that has performed more than 600 biopsies since its establishment. Although Indigenous people in Australia’s Northern Territory (NT) has the highest rate of renal replacement th
Externí odkaz:
https://doaj.org/article/09b5b3046f5145bcb645621988dd7212
Autor:
Winnie Chen, Asanga Abeyaratne, Gillian Gorham, Pratish George, Vijay Karepalli, Dan Tran, Christopher Brock, Alan Cass
Publikováno v:
BMC Nephrology, Vol 23, Iss 1, Pp 1-12 (2022)
Abstract Background Electronic health records can be used for population-wide identification and monitoring of disease. The Territory Kidney Care project developed algorithms to identify individuals with chronic kidney disease (CKD) and several commo
Externí odkaz:
https://doaj.org/article/6ba06c57df834404b17527f034d1430d
Publikováno v:
BMC Nephrology, Vol 23, Iss 1, Pp 1-9 (2022)
Abstract Background Lupus nephritis is a common manifestation of Systemic Lupus Erythematosus. Mycophenolate is recommended by guidelines for induction therapy in patients with proliferative lupus nephritis and nephrotic range proteinuria Class V lup
Externí odkaz:
https://doaj.org/article/8db2ca36fb47466181b4404f836c1da6